Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET

GlobeNewswire October 25, 2023

ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares

GlobeNewswire October 2, 2023

ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

GlobeNewswire September 18, 2023

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

GlobeNewswire September 12, 2023

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

GlobeNewswire August 28, 2023

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire August 24, 2023

ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

GlobeNewswire August 23, 2023

ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance  

GlobeNewswire August 9, 2023

ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET

GlobeNewswire July 31, 2023

ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire May 16, 2023

ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity

Business Wire May 15, 2023

ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock

Business Wire May 12, 2023

ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock

Business Wire May 11, 2023

ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

Business Wire May 8, 2023

ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET

Business Wire April 27, 2023

ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

Business Wire April 26, 2023

ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP

Business Wire April 24, 2023

ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP

Business Wire April 4, 2023

ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance

Business Wire March 9, 2023

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET

Business Wire February 22, 2023